Δ9-THCB
Δ9-THCB (Δ9-Tetrahydrocannabutol) has a high affinity for human CB1 and CB2 receptors with the Ki values of 15 nM and 51 nM, respectively. Δ9-THCB (Δ9-Tetrahydrocannabutol) has analgesic and anti-inflammatory activities and plays partial agonistic effects on CB1 receptor in mice[1].
Product Specifications
CAS Number
60008-00-6
Product Name Alternative
Δ9-Tetrahydrocannabutol
UNSPSC
12352005
Target
Cannabinoid Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
OC1=C2[C@@]3([H])[C@](CCC(C)=C3)([H])C(C)(OC2=CC(CCCC)=C1)C
Molecular Formula
C20H28O2
Molecular Weight
300.44
References & Citations
[1]Linciano P, et al. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol. J Nat Prod. 2020 Jan 24;83 (1) :88-98.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
CB1; CB2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6111831-01 1 g
3,4-Di (tetrahydropyran-2-oxy) benzaldehyde (Major)
Sign In for Pricing
View Details MBS6111831-02 5x 1 g
3,4-Di (tetrahydropyran-2-oxy) benzaldehyde (Major)
Sign In for Pricing
View Details